The world’s leading manufacturer of laboratory glass and life science packaging materials, DWK Life Sciences, announces the signing of a definitive purchase agreement of Müller + Müller at August 21st, 2020. Müller + Müller is one of the leading German manufacturers of primary packaging materials made of tubular glass for the pharmaceutical industry. The company will become part of the DWK Life Sciences group upon closing, which is expected for September. Müller + Müller will continue to serve its customers under the same name and will continue to be managed by CEO Florian Müller-Stauch. Dr. Hubertus Müller-Stauch (owner of the company Müller + Müller) will join the advisory board of DWK Life Sciences to support the further expansion of the pharma packaging division.
Müller + Müller is based in Holzminden in Lower Saxony, Germany, and currently employs 135 staff. The family-run company is a key player in the manufacture of vials and has a long history of over 95 years. Thanks to its state-of-the-art technology and continuous process optimisation, Müller + Müller meets the highest quality requirements for pharmaceutical packaging. Every year approx. 300 million glass type I vials are produced at its Holzminden site in accordance with GMP guidelines. Type I borosilicate glass is an excellent material for storing vaccines as the glass is virtually inert. This means that the container glass does not react with its contents and thus represents the standard in vaccine packaging.
“Acquiring the family business Müller + Müller is a significant strategic step for us in expanding our activities in the market for pharmaceuticals packaging,” explains CEO of DWK Life Sciences, Armin Reiche. “We are not just investing in an important growth market here, but also in a company that boasts first class production technology and highly reliable products.”
“Driven by the high demand of the vaccine industry for vials, expansion of our production capacities is the next logical step,” says Florian Müller-Stauch, CEO of Müller + Müller. “We are delighted to have found a strong and reliable partner in DWK who will allow us to further develop our business.”
DWK Life Sciences is a portfolio company of One Equity Partners, a middle market private equity firm that builds market-leading companies by identifying and executing transformative business combinations and partnering with management teams to provide operational support to accelerate growth.
Detmold-based electronics and automation specialist MSF-Vathauer Antriebstechnik is investing in new products and business units and thus also growing in the COVID-19 pandemic. The MSF-Vathauer Antriebstechnik team has developed modern and intelligent assistance systems for the healthcare sector and bundled them into an independent business unit. The resulting business unit stands for modern assistance systems for all missions that also help in everyday life.
This is how the intelligent Clean Air (CLAIR) system came into being. It is made up of the terms “CLEAN” (clean) and “AIR” (air). Whether a person falls ill with corona or not depends strongly on the infectious dose. In addition to droplets, aerosols have also been identified as carriers of viruses. They float in the air and are ingested by people. To avoid this, it is important to give special importance to air exchange. CO2 traffic lights and room air cleaners promote air quality and contribute significantly and continuously to reducing the viral load. The prerequisites are highly efficient and valid measuring devices that everyone can understand and interpret, as well as highly efficient filter technology in the room air purifiers.
Modern technology for health
Hardly any other time like this one has shown us so clearly that good air is essential for our health, because clear and clean air gives us the security to breathe freely and not only stands for health but can also promote it. Clear air in the office, at school, in the waiting room and at home – with the smart CO2 traffic light “KAY” from the CLAIR system of Vathauer MedTech from now on very easy possible.
Modern infection control “Made in Germany
Wherever it is necessary to minimize the CO2 content and the viral load in the room and wherever many people come together in a confined or closed space, the smart CO2 traffic light “KAY” finds the ideal area of application. “KAY” comes from the CLAIR system that ensures clean air thanks to smart technology – a system with brains & foresight that ensures that airborne pathogens are less likely to spread.
“KAY doctor” in action
Today, we present a user area in more detail and got into conversation with physiotherapist Mr. Claude Diening from the physiotherapy practice “Praevito” in Detmold about reasons for purchasing “KAY”, advantages of the compact CO2 traffic light as well as the current situation in his professional field.
Claude Diening, a health care professional from Lippe, decided to purchase several CO2 traffic lights because of many factors, such as safety, health assurance and customer satisfaction. All of these challenges cannot be dismissed out of hand, because where people are, there is a lot of breathing and often a lot and sometimes loud talking – and in closed rooms, the breathable air emitted in the process circulates for a long time.
As a result, the carbon dioxide concentration and the amount of aerosols in the indoor air rise steadily. In this way, pathogens such as viruses and bacteria can be further distributed. But to ventilate permanently is not the way to go, even in busy rooms such as waiting rooms treatment rooms or on the training floor. But when, how often and for how long should the rooms be ventilated? This is exactly what the CO2 traffic light “KAY” from Vathauer MedTech reliably indicates.
Physiotherapist Claude Diening: “I wanted to provide my customers, myself and my staff with a reliable way of monitoring ventilation – especially in these challenging times. And of course, I not only want to give my customers and patients a feeling of security, but also provide them with a trustworthy product that not only makes the already all too difficult daily routine easier, but also allows us to continue to carry out our profession in our premises as reliably as in the days before Corona.”
Based on recent studies and new scientific findings, it has become clear that clear, clean air in enclosed spaces and those frequented by the public is essential to prevent the spread of viruses. What impact do these assessments have on your daily work?
Physiotherapist Claude Diening: “Especially in the medical and therapeutic field, we focus on basic hygiene and clear prioritization of health. Therefore, it is even more important to me that my customers and patients have a good and safe feeling when they enter my practice rooms as well as during waiting and treatment time. A basic ventilation routine is not always easy to implement in the day-to-day running of a practice, when staff changes, appointment pressure and stressful situations come into play. That’s where a smart tool like the “KAY doctor” is extremely helpful and reliable, as it allows us to provide fresh air as needed.”
Working together on an integrated digital platform for cell and gene therapy developers
The companies ATMPS Ltd and Ori Biotech announced a global collaboration to create seamless integration between their respective data platforms to support the development of Advanced Therapies. The non-exclusive partnership will result in the integration of Ori’s proprietary CGT manufacturing platform’s data architecture with ATMPS’ HataaliTM, a secure data sharing platform, specially designed as a scalable system for advanced therapies. The combination of the two proprietary platforms will provide improved product tracking, scheduling as well as live monitoring of the manufacturing status across the entire CGT supply chain from vein to vein.
“Ori selected ATMPS’ Hataali technology for integration with our platform to allow the secure sharing of relevant process data with therapy developers, contract development and manufacturing organizations (CDMOs) and even clinicians or patients in real-time. This collaboration will provide increased visibility into the treatment process for those involved at each stage of the treatment process, The addition of established technologies from companies like ATMPS allows Ori to further its mission of enabling partners across the CGT industry to bring therapies as safely, cost effectively and quickly as possible to large numbers of patients with few alternative therapeutic options.”
– Jason C. Foster, CEO, Ori Biotech
Hataali encrypts and stores data using distributed ledger technology through a process known as hashing. This process ensures data security is protected through a system of private keys and cryptography. Hataali was the first cell orchestration platform installed in a hospital globally and ATMPS the first blockchain company to integrate with the UK National Health Service for the delivery of advanced therapies.
“Ori is an ideal partner for ATMPS, as both companies share a common mission to lower the costs and improve processes for cell and gene therapies. Ori’s work in helping innovators scale from preclinical to commercial is a massive step towards reducing complexity and bringing these vital therapies to patients more quickly,” said Raja Sharif, CEO, ATMPS. “We all know how challenging and expensive the development and manufacturing of CGTs can be. With the help of Hataali, Ori can securely leverage vein-to-vein data to advance their manufacturing solutions much more efficiently. This will enable real-time therapy tracking, improved patient trust and expediated clinical development.”
Efficient pipetting between different vessel formats
Eppendorf expanded its line-up of Move It adjustable tip spacing pipettes with four additional variants. With adjustable cone distances, the pipettes allow scientists to accelerate and simplify their workflow when pipetting between different vessel formats such as from tubes to plates.
The new electronic models feature 8 or 12 channels and volume ranges of 1–20 μL or 5–100 μL respectively. With a minimum tip distance of 4.5 mm they are perfectly suited for the 384-well plate format.
Their unique, tubeless design results in fewer moving fragile parts which improves precision and durability. The pipettes are also autoclavable – increasing user and sample safety. With a 360° rotatable pipette head and an ideal hand balance, they are highly ergonomic and reduce operating stress in the lab.
Launched in 2020, the Move It line-up has already been acknowledged with a Wiley Analytical Science Award 2021 and one of the esteemed Scientists’ Choice Awards 2021 for Best New General Lab Product of 2020. It now covers all dominant volume variants needed for different applications.
Along with the new Move It variants, Eppendorf have ramped up their production capacities for epT.I.P.S. 384 pipette tips, which are the perfect choice for 384-well pipetting and also available as filter tip.